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Abstract
Background: Childhood tuberculosis (TB) is a public health concern causing considerable mortality. However,
control of childhood TB receives little attention. The control efforts could be inadequate because of challenges
associated with difficulties in diagnosing the disease in children. Understanding the burden of the disease among
children is important to assess the ongoing transmission of the disease in a community and improving TB control
efforts. This study was carried out to assess TB case notification rates (CNRs) and treatment outcomes in children
aged less than 15 years over a ten-year period.
Methods: Data were collected from unit TB registers from all health facilities providing TB treatment in the Sidama
Zone in Ethiopia. We analysed the CNRs and treatment outcomes by age category, gender, and place of residence.
We used logistic regression analysis to identify factors associated with treatment outcomes and to control for
confounding.
Results: A total of 4,656 cases of children less than 15 years of age were notified as diagnosed and treated
for TB, constituting 13 % of all notified TB cases in the study area. The mean CNRs per 100,000 children less
than 15 years were 30 for all new cases of TB, 28 for rural cases, 67 for urban cases, 28 in boys, and 32 in
girls. The proportions of treatment success were 82 % for new and 77 % for retreatment cases for the entire
study period and increased to 93 % for new cases in 2012 (X2trend, P < 0.001). Children less than five years old
had a lower treatment success [adjusted odds ratio (AOR) 0.64 (95 % CI, 0.52-0.80)] and higher deaths [AOR 2
(95 % CI, 1.27–3.12)]. The proportion of children who died during treatment among children in the less than
2-year-old age group was three times higher than children in the 2 year and above age groups [AOR 3.34
(95 % CI, 1.92–5.82)].
Conclusion: The CNRs of childhood TB were low in Sidama. Children less than 5 years old had a higher
proportion of deaths. Efforts need to be made to improve the diagnosis and treatment of TB among children.
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Background
Childhood tuberculosis (TB) is a public health concern
causing considerable mortality [1–3]. In 2013, approxi-
mately 550,000 new cases of TB and 80,000 deaths oc-
curred in children who were HIV-negative [2]. However,
childhood TB has been addressed inadequately in re-
source constrained settings due to challenges associated
with difficulties in diagnosis and treatment of the disease
[3, 4]. Lack of trained human resources to deliver the
services, high cost related to training and to provision of
services, and limited diagnostic facilities are some of the
challenges for childhood TB diagnosis and control [5].
On the other hand, low case notification rates (CNRs) of
TB in children could be because of underdiagnoses,
underreporting, and due to the lower priority that the
health systems give for children with TB compared to
adults [6, 7]. In areas with poor access to diagnostic
facilities and skilled personnel, children could suffer
from the disease even without being diagnosed, or they
are diagnosed late. Late diagnosis can contribute to con-
siderable childhood deaths and to the transmission of
the disease.
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In Ethiopia, the National TB Control Program decen-
tralized and expanded the directly observed treatment
short course (DOTS) strategy. However, the existing TB
control programs may have limitations in addressing
childhood TB. The national TB prevalence survey of
Ethiopia did not report the estimates of TB burden in
children [8]. There is also limited information on age
disaggregated case notification and treatment outcomes
in routine surveillance system.
The burden of TB in children can serve as an indicator
to assess effectiveness of TB control programs, and one
of the indications for the ongoing transmission of the
disease in a community [9]. Therefore, generating infor-
mation from surveillance data is useful for understand-
ing the burden of the disease in a community and such
information could provide essential evidence for improv-
ing tuberculosis control [6, 7]. The objective of this
study is to assess case notification rates and treatment
outcomes of childhood TB over a ten-year period in the
Sidama Zone in southern Ethiopia.
Methods
Study setting
The study was conducted in the Sidama Zone in south-
ern Ethiopia, which is one of the most densely populated
areas in Ethiopia with a population of over 3.4 million.
Ninety-two per cent of the population live in the rural
areas, and agriculture is the major livelihood of the com-
munity. Administratively, the Sidama Zone is divided
into 19 woredas (districts) and two towns. There are 524
rural and 39 urban kebeles (the lowest administrative
unit for about 5,000 people or 1000 households on aver-
age). In 2012, 114 health facilities provided TB treatment
and 81 health facilities carried out sputum-smear exam-
ination. Ninety-five percent of the districts in the study
area had at least one antiretroviral treatment (ART)
centre. The demographic and health survey of Ethiopia
estimated the adult HIV prevalence in the southern re-
gion of Ethiopia, where the present study was con-
ducted, to be approximately 1 % [10]. In 2011, a
community based intervention was implemented aimed
at improving TB case finding and treatment outcomes
[11]. In 2012, there were only two health facilities with
radiographic services.
TB diagnosis and treatment definition
We used the National TB control guideline of Ethiopia
for diagnosis and treatment, case definition, and treat-
ment outcomes [12].
Smear-positive pulmonary TB (PTB) is diagnosed with
at least two positive initial sputum smears for Acid Fast
Bacilli (AFB) by direct microscopy, or one positive smear
for AFB by direct microscopy and culture positive for
Mycobacterium tuberculosis or one positive smear for
AFB by direct microscopy and radiographic abnormal-
ities consistent with active TB as determined by a clin-
ician. The laboratory keeps all positive and negative
slides for external quality assurance. Quality assurance is
performed regularly at the regional laboratory, and feed-
back is given to a reporting health facility. Previous stud-
ies reported a high specificity and good agreement of
sputum-smear microscopy for AFB between peripheral
and reference laboratories [11, 13].
Smear-negative pulmonary TB (PTB) is diagnosed
when the patient presents with symptoms suggestive of
TB, has at least three initial smear examinations negative
for AFB, no response to antibiotics, repeat smear-
negative and radiological abnormalities consistent with
pulmonary TB, as well as a clinician’s decision.
Extra pulmonary TB (EPTB) is diagnosed by one
culture-positive specimen from an extra pulmonary site
or histopathological evidence from a biopsy, which is
based on strong clinical evidence consistent with active
EPTB by a clinician’s decision. However, most health fa-
cilities diagnose the disease based on a clinician’s deci-
sion because there are inadequate laboratory facilities for
sputum culture or histopathology. The body sites for
EPTB are lymph nodes, intestine, bone, kidney, central
nervous system, and other organs.
A short-course treatment regimen is given in two
phases with fixed-dose combination first-line anti-TB
drugs [12]. The intensive phase treatment lasts for two
months with ethambutol (E), isoniazid (H), rifampicin
(R) and pyrazinamide (Z) followed by a continuation
phase of six-month with ethambutol and isoniazid. Since
2011, the continuation phase has lasted for four months,
and uses isoniazid and rifampicin.
“Cured” is smear-positive TB patient who is sputum
smear-negative at, or one ‘month’ prior to the comple-
tion of treatment and on at least one previous occasion.
“Treatment completed” is a TB patient who completed
treatment but for whom smear results are not available
one month prior to the completion of treatment.
“Treatment success” is patients who was declared
“cured” or “treatment completed”
Data collection
The data were collected from August 2012 to February
2013 from all DOTS providing health facilities during
2003 to 2012. We collected unit TB registers from all
health facilities in the study area and included the fol-
lowing variables: address of the patient, name of the
health facility, age, sex, smear result, TB category, TB
classification, intensive phase treatment drugs, year of
treatment, date of treatment started, last date of treat-
ment, and treatment outcomes. The treatment results
included treatment completed, cured, defaulted (lost-to-
follow up), died, transferred out, treatment failure, and
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unknown. We could not collect the data of nutritional
status and HIV status of the children because the data
were not recorded in the unit TB registers. Address of
patients consisted of actual district and kebele of the
patient at the time of diagnosis. Data entry personnel
were university graduates with experience of data man-
agement. Training was given to data collectors and the
data were double entered. We cross checked the data for
the number of cases by year, facilities and districts as
well as the correctness and consistency of information.
The data were entered using Microsoft Access and
exported to IBM SPSS (Statistics for Windows, Version
20.0. Armonk, NY: IBM Corp).
We supervised the data entry for completeness and
consistency on regular basis. To ensure data quality we
checked consistency and correctness of entered informa-
tion with information in the TB registers. We did an ex-
ploratory analysis, looked for errors and corrected them
from the registers. Number of cases and patient infor-
mation entered by each year and health facility were
checked with information in unit TB register page by
page and year of treatment to ensure data completeness
and accuracy.
Statistical analysis
Case notification and treatment outcomes were com-
puted for smear positive PTB, smear negative PTB and
EPTB cases. We obtained each year’s population data for
the study area from Central Statistical Agency of
Ethiopia (CSA) [14] and computed case notification
rates using under 15 years population for different years
by age category as a denominator and notified cases as a
numerator. We used IBM SPSS 20 for data analysis.
Multivariate logistic regression analysis was performed
to determine independent risk factors associated with
treatment outcomes and to control for confounding.
Ethical consideration
We obtained ethical clearance from the Regional Health
Bureau of southern Ethiopia, in addition to a letter of
support from the Sidama Zone Department of Health, to
obtain information from all districts and health facilities.
Personal identifiers of the cases were coded prior to ana-
lysis and medical records were kept in a secure place to
help maintain the confidentiality of clinical information
of cases.
Results
A total of 4,656 cases of children less than 15 years
of age were notified as diagnosed and treated for tu-
berculosis from 2003 through 2012, constituting about
13 % of cases of all age groups notified in the study
area. Fifty-two percent (2,434 cases) of the cases were
girls and 48 % (2,220 cases) were boys. Fifteen
percent (719 cases) of the cases were less than five
years old and 2,433 cases (53 %) were in the 10–14-
year-age group. Of the cases, 4,087 (88 %) were from
rural areas, 1,956 cases (42 %) were smear-positive
PTB, and 1,308 (28 %) were smear-negative PTB
cases (Table 1). The proportion of smear-positive PTB
in the younger age group (less than 5 years) was
lower than the proportions among 5–9 and 10–14
year-age groups (Table 2).
Case notification rates
The mean CNRs for new cases of TB of all forms were
30 per 100,000 children, 67 in urban and 28 in rural
areas, and 32 in girls and 28 in boys per 100,000 chil-
dren. No decline was observed in childhood TB over a
ten-year study period (Fig. 1 and Table 3). The mean
CNR of smear-positive PTB was about 13 per 100,000
children and increased from 11 in 2003 to 16 per
100,000 in 2012. The mean CNRs of smear-positive PTB
were 14 for girls and 11 for boys per 100,000 children
(Table 4).
Treatment outcome
The proportions of treatment success were 82 % for new
and 77 % for retreatment cases, and increased to 93 % in
2012 for new cases (X2 trend, P < 0.001) (Table 3). The
proportion of cases lost-to-follow up declined from 20 %
in 2003 to 1 % in 2012 (X2 trend, P < 0.001). Children
less than five years old had a lower treatment success
[AOR 0.64 (95 % CI, 0.52–0.80)] while the treatment
success was higher in the 10-14 year-age group com-
pared to 5–9 year olds [AOR 1.60 (95 % CI, 1.30–1.86)].
A considerable improvement was observed in treatment
success in 2011–2012 (Table 5).
The proportion of childhood TB cases who died was
3 % (140 cases), constituting 12 % of the 1,202 deaths
from TB in all age groups notified during the study
period. The proportion of cases who died while on
treatment declined from 7 % in 2003 to 2 % in 2012 (X2
trend, P < 0.001), and was higher among under five-year
age group [AOR 2.00 (95 % CI, 1.27–3.12)], and less in
EPTB cases [AOR 0.58 (95 % CI, 0.36–0.95)]. The pro-
portion of children who died in the less than 2-year-age
group was three times higher than in the 2 year and
above age groups [AOR 3.34 (95 % CI, 1.92–5.82)].
The proportions of cases lost-to-follow up and who
died while on treatment were less in the 10–14 year
olds than the younger age groups. Notable improve-
ments in treatment success, loss-to-follow up, and
mortality were observed by years of treatment, and
the highest improvement in treatment outcome was
observed in 2011–2012 (Table 5).
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Table 1 General characteristics of the tuberculosis cases among children 0–14 years and all age groups in the Sidama Zone,
2003–2012
Characteristics Childhood TB(Age 0–14 years) Total notified cases (All age groups) Proportion of childhood TB
N (%) N (%) %
Sex
Male 2,220 (48) 20,193 (54.5) 11
Female 2,434 (52) 16,867 (45.5) 14.4
Age category
<5 740 (16) - -
5–9 1,430 (31) - -
10–14 2,486 (54) - -
Residence
Urban 559 (12) 5,158 (14) 10.8
Rural 4,087 (88) 31,912 (86) 12.8
TB classification
Pulmonary smear positive 1,956 (42) 22,545 (61) 8.7
Pulmonary negative 1,307 (28) 7,980 (22) 16.4
Extra pulmonary 1,379 (30) 6,464 (17) 21.3
Not mentioned 14 (0.3) 72 (0.2) 19.4
Patient category
New 4,545 (98) 35,314 (95.3) 12.9
Retreatment 90 (1.9) 1,641 (4.4) 3.4
Transferred in 16 (0.3) 102 (0.3) 29.4
Not mentioned 5 (0.1) 13 (0) 38.4
Treatment outcomes
Completed 2,586 (55.5) 16,161 (44) 16
Cured 1,187 (25.5) 14,205(38) 8.4
Lost-to-follow up 482 (10.4) 3,284 (9) 14.7
Died 140 (3.0) 1,202 (3.2) 11.6
Transferred 109 (2.3) 874 (2.4) 12.5
Treatment failure 9 (0.2) 92 (0.2) 9.8
Unknown 143 (3.1) 1,252 (3.4) 11.4
Year of treatment
2003 367 (7.9) 2,341 (6.3) 15.7
2004 387 (8.3) 2,705 (7.3) 14.3
2005 369 (7.9) 2,774 (7.5) 13.3
2006 349 (7.5) 2,523 (6.8) 13.8
2007 483 (10.4) 3,296 (8.9) 14.7
2008 527 (11.3) 4,125 (11.1) 12.8
2009 433 (9.3) 3,499 (9.4) 12.4
2010 385 (8.3) 3,303 (8.9) 11.7
2011 662 (14.2) 5,643 (15.2) 11.7
2012 694 (14.9) 6,846 (18.5) 10.1
Total cases 4,656 37,070 12.6
The year of treatment was not mentioned for 15 cases for all age groups
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Discussion
We found low CNRs of childhood TB in Sidama. Our
data show that the CNR in children was lower than
other reports from developing countries [15, 16].
We analysed the CNRs based on age specific risk for de-
veloping TB, and challenges associated with its diagnosis
[17, 18]. The low CNR among young children (less than
5 years old) in our finding could be explained by underre-
porting, difficulties in diagnosis of childhood TB due to
distinct clinical features of the disease in young chil-
dren [18], poor access to diagnostic facilities such as
chest radiography and culture, and poor access to
skilled health personnel to diagnose the disease in
children. Instituting better diagnostic services such as









Number of TB cases (N) 1,956 1, 307 1,379 4642
Sex
Girls 1092 (56) 653 (50) 681 (49) 2,426 (52)
Boys 863 (44) 654 (50) 698 (51) 2,215 (48)
Age category
<5 130 (7) 362 (28) 244 (18) 736 (16)
5–9 494 (25) 453 (35) 478 (35) 1,425 (31)
10–14 1332 (68) 492 (38) 657 (47) 2,481 (53)
Residence
Urban 178 (9) 193 (15) 198 (14) 569 (12)
Rural 1778 (91) 1114 (85) 1181 (86) 4,073 (88)
Patient category
New 1902 (98) 1278 (98) 1359 (99) 4,539 (98)
Repeat 47 (2) 266 (1.2) 16 (1) 89 (2)
Transferred 7 (1) 1 (1) 4 (0.3) 12 (0.3)
Treatment outcomes
Completed 419 (21) 1038 (79) 1128 (82) 2,585 (56)
Cured 1184 (61) NA NA 1,184 (26)
Lost-to-follow up 170 (9) 147 (11) 159 (12) 476 (10)
Died 55 (3) 58 (4.4) 27 (2) 140 (3)
Transferred 42 (2.1) 33 (2.5) 33 (2.4) 108 (2.3)
Treatment failure 8 (0.4) NA NA 8 (0.2)
Unknown 78(4) 31 (2.3) 32 (2.3) 140 (3)
Year of treatment
2003 132 (7) 134 (10) 101 (7) 367 (8)
2004 153 (8) 101 (8) 132 (10) 386 (8)
2005 149 (8) 83 (6) 136 (10) 368 (8)
2006 145 (7) 93 (7) 107 (8) 345 (7)
2007 154 (8) 148 (11) 180 (13) 482(10)
2008 209 (11) 131 (10) 181 (13) 521 (11)
2009 184 (9) 129 (10) 119 (9) 432 (9)
2010 178 (9) 117 (9) 89 (7) 384 (8)
2011 373 (19) 124 (10) 165 (12) 662 (14)
2012 279 (14) 246 (19) 169 (12) 694 (15)
aFor 13 cases TB classification was not mentioned
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Fig. 1 Case notification rates of TB of all forms among children in the Sidama Zone in southern Ethiopia, 2003–2012
Table 3 Characteristics of case notification rates and treatment outcomes of new cases of TB (4,545 cases) notified among children

















New cases of TB all forms 30 2532 (56) 1162 (26) 464 (10) 136 (3) 104 (2) 9 (0.2) 138 (3)
Sex
Girls 32.0 1299 (51) 666 (28) 225 (10) 74 (3) 50 (2) 4 (0.2) 61 (3)
Boys 28.0 1233 (57) 496 (30) 225 (11) 62 (3) 54 (3) 5 (0.2) 75 (3)
Age category
<5 15.3 459 (64) 47 (6.5) 128 (18) 44 (6) 21 (3) 1(0.1) 19 (3)
5–9 24.2 835 (60) 268 (19) 155(11) 41 (3) 37 (3) 4 (0.3) 53 (4)
10–14 53.0 1238 (51) 847 (35) 181 (8) 51 (2) 46 (2) 3 (0.2) 66 (3)
Residence
Urban 67.0 368 (66) 88 (16) 54 (10) 16 (3) 13 (2) 1 (0.2) 14 (3)
Rural 28.0 2164 (54) 1074 (27) 410 (10) 120 (3) 91 (2) 8 (0.2) 124 (3)
TB classification
Smear positive PTB 12.4 406 (21) 1161 (61) 158 (8) 53 (3) 39 (2) 8 (0.4) 77 (4)
Smear negative PTB 8.4 1013 (79) NA 147 (12) 56 (4) 33 (3) NA 30 (2.3)
EPTB 9.0 1112 (82) NA 157 (12) 27 (2) 32 (2) NA 31 (2)
Year of treatment
2003 29.3 175 (48) 86 (24) 73 (20) 27 (7) 2 (1) 1 (0.3) 0
2004 28.5 199 (54) 72 (19) 54 (15) 16 (4) 15 (4) 0 15 (4)
2005 26.4 217 (60) 67 (19) 28 (8) 8 (2) 14 (4) 1 (0.3) 25 (7)
2006 23.7 197 (58) 56 (17) 45 (13) 11 (3) 7 (2) 0 23 (7)
2007 31.9 314 (66) 76 (16) 56 (12) 17 (4) 7 (2) 0 9 (2)
2008 32.7 309 (61) 111 (22) 60 (12) 9 (2) 7 (1) 1 (0.2) 8 (2)
2009 26.4 234 (56) 82 (20) 61 (15) 10 (2) 15 (4) 3 (1) 15 (4)
2010 23.0 198 (53) 76 (20) 60 (16) 10 (3) 16 (4) 0 16 (4)
2011 38.7 305 (47) 289 (44) 21 (3) 16 (3) 11(2) 1 (0.2) 9 (1)
2012 38.5 384 (57) 247 (36) 6 (1) 12 (2) 10 (2) 2 (0.3) 17 (3)
Retreatment cases NA 27 (46) 18 (31) 6 (10) 3 (5) 3 (5) 0 2 (3)
NA not applicable
CNRs = the mean case notification rates over a ten-year period except for the year of treatment category
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interferon-gamma release assays, culture, and nucleic
acid amplification tests could help improve diagnosis
and treatment of childhood TB [19].
The higher CNRs among older children (10–14 years)
in our data could be because the clinical features of the
disease are often similar to adults, and there is a better
yield of sputum-smear examination among older chil-
dren [17, 20]. The higher CNRs in urban areas than in
rural areas could be explained by better access to TB
diagnostic facilities, better education and awareness of
the parents and early health seeking, and this finding
was in agreement with a study from Tanzania [21]. Like-
wise, in an earlier study, we found a higher CNR of TB
among adults in urban areas [22].
The proportion of childhood TB cases in our data
(13 %) was lower than the national estimate and report
[2, 6]. Our finding was in agreement with a previous re-
port from the study area (13 %) [23], and higher than
the global report (6 %) [2]. Other studies also report
childhood TB constitutes 10-20 % of the disease burden
in endemic areas [17].
From Ethiopia, one study from an urban setting re-
ported a lower proportion (6.6 %) [24], and another
study from a rural hospital [25] reported a higher pro-
portion (46 %) of childhood TB than our finding. The
reported higher proportion could be because the study
was conducted in hospital setting which could have bet-
ter diagnostic setup for children and could be due to re-
ferral cases who come from high burden areas due to
poor access to TB diagnosis and treatment facilities. The
lower proportion of childhood TB for the former study
[24] could be due to underreporting or due to the lower
burden of the disease. Nevertheless, both studies did not
report the CNRs of childhood TB per 100,000 children
unlike our report. Thus, the differences in the proportion
of childhood TB from both studies and our finding could
be partly explained by differences in study settings because
we conducted the study in both urban-rural settings, in all
DOTS providing health facilities, and we linked TB cases
to their true home address to compute the case notifica-
tions to avoid under- or over reporting [22].
In our study, we noted that more girls than boys had
smear-positive TB in the 10–14-year age group. This
could reflect, at least in part, that girls enter puberty
earlier and therefore might develop adult type of PTB
earlier than boys [19, 26]. In our data, the proportion of
Table 4 Characteristics of case notification rates and treatment outcomes of new smear-positive PTB cases in children in the Sidama
Zone, 2003–2012












New PTB+ cases 12.6 406 (21) 1161 (61) 158(8) 53(3) 39(2) 8(0.4) 77 (2)
Sex
Girls 14 229 (22) 665 (62) 85 (8) 29 (3) 17 (2) 3 (0.3) 38 (3.6)
Boys 11 177 (21) 496 (59) 73 (9) 24 (3) 22 (3) 5 (0.6) 38 (3.8)
Age category
<5 3 38(30) 47(37) 24 (19) 10 (8) 6 (5) 0 2 (1.6)
5–9 8 107 (22) 267 (56) 48 (10) 14 (3) 9 (2) 4 (0.8) 30 (6.3)
10–14 28 261 (20) 847 (65) 86 (7) 29 (2) 24 (2) 4 (0.3) 45 (3.5)
Residence
Urban 21 54 (31) 88 (51) 16 (9) 3 (2) 4 (2) 1 (0.6) 7 (4)
Rural 12 352 (20) 1073 (62) 142 (8) 50 (3) 35 (2) 7 (0.4) 70 (4)
Year of treatment
2003 10.6 18 (14) 86 (65) 17 (13) 10 (8) 0 1 (0.8) 0
2004 11.4 41 (28) 72 (47) 19 (13) 4(3) 3 (2) 0 9 (6)
2005 10.5 44 (31) 67 (47) 7 (5) 5 (4) 4 (3) 1 (0.7) 16 (11)
2006 9.8 42 (30) 56 (40) 14 (10) 6 (4) 4 (3) 0 18 (13)
2007 10.2 49 (32) 76 (50) 20 (13) 3(2) 2 (1) 0 3 (2)
2008 12.7 59 (30) 111 (56) 19 (10) 1 (0.5) 4 (2) 1 (0.5) 2 (1)
2009 11.1 47 (27) 82 (47) 24 (14) 4 (2) 8 (5) 2(1) 9 (5)
2010 10.6 52 (30) 75 (43) 29 (17) 4 (2) 5 (3) 0 9 (5)
2011 21.7 44 (12) 289 (79) 7 (2) 6 (2) 6 (2) 1 (0.3) 6 (1.6)
2012 15.5 10 (3.7) 247 (91) 2 (1) 4 (2) 3 (1) 2 (0.7) 5 (2)
CNR* =mean case notification rate per 100,000 children except for the year of treatment category
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TB cases in children less than 5-year old was lower
than in children 5–9-year old. In high burden setting
with a broad-based population pyramid, the number
of cases in children less than 5 and 10–14-year age
groups are often higher than in the 5–9-year age group
[4, 24]. The lower CNR in the younger age group in
our study suggests TB in the less than 5-year age
group could be underdiagnosed.
The proportion of smear-positive PTB among all pul-
monary TB cases was higher than other reports from
Ethiopia [24] and elsewhere [21, 27]. Evidence shows
that children usually have approximately 10–15 %
smear-positive TB [4]. The difference in our finding is
most likely because of underdiagnosing of smear-
negative cases, particularly in younger children. This
suggests concerted efforts to improve the diagnoses of
TB in the younger age group.
In our data, the proportions of children successfully
treated were higher among older age groups than
among younger children, as has been shown from
other studies from Ethiopia [23, 24] and elsewhere
[28]. Nevertheless, there is a growing concern on TB
treatments in children, which are not “child-friendly”
and TB drugs for children may not be in the correct
dose, and the reports suggest “simple and safe
treatments designed for children” [29]. The pro-
portion of cases who died during treatment among
children constituted about 12 % of the total deaths of
TB in all age groups during the study period.
However, the overall case fatality during treatment
Table 5 Various factors associated with treatment success, loss-to-follow up and mortality among new cases of TB in children under
15 years in the Sidama Zone, 2003–2012
Characteristics of
cases
Treatment success Lost-to-follow up Mortality
% Adjusted OR (95 % CI) P-value % Adjusted OR (95 % CI) P-value % Adjusted OR (95 % CI) P-value
Gender
Girls 82.6 1.00 9.5 1.00 3.1 1.00
Boys 79.9 0.84 (0.72–0.98) 0.028 11.0 1.26 (0.95–1.42) 0.136 2.9 0.90 (.64–1.28) 0.577
Age
0–4 years 70.4 0.64 (0.52–0.80) <0.001 17.8 1.68 (1.29–2.20) <0.001 6.1 2.00 (1.27–3.12) 0.003
5–9 years 79.2 1.00 11.1 1.00 2.9 1.00
10–14 years 85.7 1.60 (1.30–1.86) <0.001 7.4 0.694 (0.55–0.86) 0.002 2.1 0.72 (0.47–1.10) <0.129
<2 years 65.5 0.49 (0.35–0.69) <0.001 18.1 1.58 (1.04–2.41) 0.032 10.5 3.34 (1.92–5.82) <0.001
≥2 years 81.9 1.00 9.9 2.7 1.00
Residence
Urban 82.3 1.00 9.7 1.00 2.9 1.00
Rural 81.1 0.83 (0.65–1.06) 0.131 10.3 1.20 (0.88–1.62) 0.265 3.0 1.08 (.65–1.92) 0.680
TB classification
Smear positive PTB 82.4 1.00 8.3 1.00 2.8 1.00
Smear Negative PTB 79.2 1.07 (0.88–1.31) 0.476 11.5 1.06 (0.82–1.40) 0.647 4.4 1.15 (0.76–1.75) 0.499
Extra pulmonary TB 81.8 1.18 (0.97–1.42) 0.098 11.6 1.18 (0.93–1.51) 0.181 2.0 0.58 (0.36–0.95) 0.029
Year of treatment
2003 71.7 1.00 20.1 1.00 7.4 1.00
2004 73.0 1.05 (0.76–1.46) 0.756 14.6 0.68 (0.46–1.01) 0.057 4.3 0.60 (0.32–1.14) 0.121
2005 78.9 1.44 (1.02–2.04) 0.038 7.80 0.34 (0.21–0.54) <0.001 2.2 0.31 (0.14–0.69) 0.004
2006 74.6 1.14 (0.81–1.71) 0.443 13.3 0.60 (0.40–0.91) 0.016 3.2 0.46 (0.22–0.94) 0.033
2007 81.4 1.68 (1.12–2.34) 0.002 11.7 0.53 (0.36–0.76) 0.001 3.5 0.50 (0.27–0.93) 0.030
2008 83.2 1.90 (1.36–2.64) <0.001 11.9 0.55 (0.38–0.81) 0.002 1.8 0.26 (0.12–0.57) 0.001
2009 75.2 1.11 (0.81–1.54) 0.517 14.5 0.73 (0.50–1.07) 0.105 2.4 0.34 (0.16–0.71) 0.004
2010 72.9 0.98 (0.71–1.37) 0.894 16.0 0.84 (0.57–1.22) 0.354 2.7 0.37 (0.18–0.78) 0.009
2011 91.1 3.64 (2.55–5.21) <0.001 3.2 0.15 (0.09–0.25) <0.001 2.5 0.38 (0.20–0.72) 0.003
2012 93.1 5.16 (3.54–7.52) <0.001 0.9 0.037(0.02–0.09) <0.001 1.8 0.24 (0.12–0.50) <0.001
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was 3 %, which is lower than a previous report from
the study area [23].
We found that very young children (less than 2 years
age) had poor treatment outcomes compared to children
two and above years old, and this finding is consistent
with other studies from Ethiopia, which report a higher
mortality among young children [23, 24]. The possible
reasons for poor treatment outcomes in younger chil-
dren could be disseminated disease, poor or immature
immunity, and late diagnosis of the disease. Many fac-
tors could also contribute to a higher risk of death in
young children such as severe form of TB [1, 6], and co-
morbidities such as malnutrition, HIV infection and
pneumonia [4, 18, 24, 30]. Interventions such as contact
tracing of adults with TB, which could help earlier diag-
nosis of the disease in the younger children is suggested
to improve the treatment outcomes Additional file 1.
A study from Ethiopia conducted in urban setting re-
ported an increased risk of mortality during treatment in
the younger children and in children with TB/HIV co-
infection [24]. We could not include the HIV status and
the nutritional status of children in the risk analysis of
treatment outcomes because the HIV and nutritional
status of children were not recorded in the unit TB reg-
isters. Childhood malnutrition is a common health prob-
lem in the study area [10], and many children could be
undernourished and this increases the risk of death
among younger children.
Lastly, we found a noticeable reduction in mortality
and loss-to-follow up and an increase in treatment
success in 2011–2012. This could be due to commu-
nity based interventions [11] and the accelerated ex-
pansion of TB diagnostic and treatment facilities in
the study area [22, 31, 32], which have improved ac-
cess to TB control services and early diagnosis of the
disease. The regimen change of the continuation
phase to rifampicin and isoniazid in 2011–2012,
which have shortened the period of treatment, could
also contribute to the observed decline in the propor-
tion of lost-to-follow up cases among children.
The limitations of our study are that we could not
confirm the diagnosis of the cases which may affect
the case notification rates. We could not ascertain the
HIV status of the children in our data to consider for
the risk analysis of treatment outcomes; however, the
prevalence of HIV in rural areas of southern region
of Ethiopia is as low as 1 % [10], and may not sig-
nificantly affect our results. We could not include the
nutritional status of children because of inadequate
data from the unit TB registers which could affect
the treatment outcome. Misclassification of the
diagnosis and treatment outcome is likely; however,
most of the smear negative and extra pulmonary
cases are diagnosed at hospitals which have better
diagnostic facilities and health personnel than the per-
ipheral health centres.
Conclusion
We found that low CNRs of childhood TB and a higher
mortality among younger children. Concerted effort
should be made to improve diagnostic and treatment fa-
cilities for childhood TB as well as targeting intervention
for high risk groups. Including HIV and nutritional sta-
tus of the children in the risk analysis improves our un-
derstanding of predictors of mortality during treatment.
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